CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Comparative Effects of Sodium-Glucose Cotransporter 2 Inhibitor and Thiazolidinedione Treatment on Risk of Stroke among Patients with Type 2 Diabetes Mellitus
Seung Eun Lee, Hyewon Nam, Han Seok Choi, Hoseob Kim, Dae-Sung Kyoung, Kyoung-Ah Kim

DOI: https://doi.org/10.4093/dmj.2021.0160

Excel Download

402-P: Comparison of the Effects of Sodium–Glucose Cotransporter 2 Inhibitor and Thiazolidinedione Treatment on Risk of Stroke among Patients with Type 2 Diabetes
SEUNG EUN LEE, HYEWON NAM, HAN SEOK CHOI, KYOUNG-AH KIM
Diabetes. 2020;69(Supplement_1):   Crossref logo
Link1 Link2
799-P: Comparison of the Effects of Sodium-Glucose Cotransporter 2 Inhibitor and Thiazolidinedione Treatment on Risk of Atrial Fibrillation among Patients with Type 2 Diabetes
SEUNG EUN LEE, YOO RI KIM, HYEWON NAM, HOSEOB KIM, JAEHWAN KIM, KYOUNG-AH KIM
Diabetes. 2021;70(Supplement_1):   Crossref logo
Link1 Link2
Risk of atrial fibrillation development of sodium-glucose co-transporter 2 inhibitor and thiazolidinedione treatment among patients with type 2 diabetes
Y.R Kim, S.E Lee, K.A Kim
European Heart Journal. 2021;42(Supplement_1):   Crossref logo
Link1 Link2
PO-685-03 EFFECT OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR AND THIAZOLIDINEDIONE ON NEW ONSET ATRIAL FIBRILLATION RISK IN PATIENTS WITH TYPE 2 DIABETES
Yoo Ri Kim
Heart Rhythm. 2022;19(5):S376-S377   Crossref logo
Link1 Link2
Neutrophil to Lymphocyte ratio is significantly reduced after Sodium glucose cotransporter-2 inhibitor treatment in patients with type 2 diabetes mellitus
Ozge Kurtkulagi
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine). 2022;18(2):86-89   Crossref logo
Link1 Link2
162-LB: Pharmacokinetics, Pharmacodynamics, and Tolerability of Single- and Multiple-Dose of Janagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, in Chinese Patients with Type 2 Diabetes Mellitus
YANHUA DING
Diabetes. 2019;68(Supplement_1):   Crossref logo
Link1 Link2
Metabolic and hemodynamic effects of sodium-dependent glucose cotransporter 2 inhibitors on cardio-renal protection in the treatment of patients with type 2 diabetes mellitus
Atsunori Kashiwagi, Hiroshi Maegawa
Journal of Diabetes Investigation. 2017;8(4):416-427   Crossref logo
Link1 Link2
Model-based Prediction of the Long-term Glucose-Lowering Effects of Ipragliflozin, a Selective Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor, in Patients with Type 2 Diabetes Mellitus
Masako Saito, Atsunori Kaibara, Takeshi Kadokura, Junko Toyoshima, Satoshi Yoshida, Kenichi Kazuta, Eiji Ueyama
Diabetes Therapy. 2020;11(4):951-964   Crossref logo
Link1 Link2 Link3
PDB7 ASSESSMENT OF CARDIOVASCULAR OUTCOMES ASSOCIATED WITH SODIUM GLUCOSE COTRANSPORTER 2 (SGLT2) INHIBITOR THERAPY AND INCRETIN-BASED THERAPIES AMONG ELDERLY PATIENTS TYPE 2 DIABETES MELLITUS
S. Korgaonkar, Y. Yang, J. Pitcock, J. Sherman
Value in Health. 2020;23:S108-S109   Crossref logo
Link1 Link2
Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
Eva Vivian
The Diabetes Educator. 2015;41(1_suppl):5S-18S   Crossref logo
Link1 Link2 Link3